Intelligence Profile
Research Papers
Research Papers and Clinical Trials
The current research on alpha-lipoic acid spans several therapeutic applications, though the available evidence varies considerably across different conditions.
Clinical Applications
A systematic review and meta-analysis published in Pharmacopsychiatry (2026) examined alpha-lipoic acid among other nutraceuticals for managing antipsychotic-induced weight gain in schizophrenia spectrum disorders. However, specific sample sizes and efficacy data for alpha-lipoic acid alone are not detailed in the available information.
Preclinical Research
Recent laboratory studies have explored alpha-lipoic acid's potential in various applications:
Hepatoprotection: A 2026 study in Scientific Reports investigated alpha-lipoic acid combined with glycyrrhetinic acid in nanophytosomes as a strategy to reduce cisplatin-induced liver damage, though this remains in early experimental stages.
Drug delivery: Research published in Macromolecular Bioscience (2026) examined lipoic acid derivatives in nanoparticle formulations for mRNA delivery, representing novel pharmaceutical applications rather than direct therapeutic use.
Reproductive medicine: A scoping review in the Journal of Ovarian Research (2026) included alpha-lipoic acid among antioxidants studied for ovarian tissue preservation, though specific outcomes for this compound are not detailed.
Completed Clinical Trials
Several clinical trials have investigated alpha-lipoic acid:
Cancer-related hearing loss: A Phase 2/3 trial (NCT00477607) examined alpha-lipoic acid for preventing cisplatin-induced hearing loss in cancer patients. The study is completed, but results are not provided in the available data.
Cardiovascular applications: An early-phase trial (NCT03136029) investigated exercise and nitric oxide effects in heart failure patients, which appears to have included alpha-lipoic acid components.
Antioxidant effects: A completed study (NCT02157207) examined racial and aging effects of acute antioxidant supplementation, potentially including alpha-lipoic acid.
Limitations
The current evidence base shows significant gaps. While multiple studies reference alpha-lipoic acid, many focus on combination treatments or novel delivery methods rather than standalone therapeutic efficacy. Sample sizes, specific dosing protocols, and detailed outcomes for most studies are not available in the provided evidence, limiting the ability to draw firm conclusions about clinical effectiveness.
Disclaimer: This information is for educational purposes only and should not replace professional medical advice. Consult healthcare providers before starting any supplementation regimen.